hotspot -WSS

hotspot

author：explore 2025-10-02 00:52:58 - browse：185

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

GSK Flovent asthma inhalers replaced by authorized generics

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

'Null' research findings aren't empty of meaning. Let's publish them

CDC recommends RSV monoclonal antibody for infants

Late stage cancers on the rise after pandemic delayed screenings

The a glaring gap in research on serious mental illness and primary care

hotspot

hotspot

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Antibiotic resistance and the global rise in human conflict

As demand for Covid shots wanes, Moderna seeks its next success

Antibiotic resistance and the global rise in human conflict

Psychedelics group wrestles with new pharma identity

Why psychiatrists like me stop taking insurance

Walensky prepares to leave CDC — and Congress — behind

Chris Christie meets with Zelenskyy during Ukraine trip

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Goldman Sachs launches $650M fund for life science investments

leisure time

Personalized medicine goes far beyond genetics

A controversial new treatment promises to make little people taller

JPM: CVS says Medicare Advantage patients are impacting profits

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Flint parents haunted by uncertainty, fears of lead poisoning

H.R. 3 is the wrong path to lower drug costs

hotspot

Wikipedia

explore

focus